The NAVIPP Kick-Off Meeting aimed to set the stage for the project’s strategic and operational framework, fostering collaboration among partners to address epidemic and pandemic viral threats through research and innovation.
NAVIPP represents a collaborative effort among esteemed international research institutions, pharmaceutical entities, and public health organizations. At its core, NAVIPP seeks to establish an international platform dedicated to the development of broad spectrum antiviral drugs targeting pathogens with pandemic potential. This groundbreaking initiative is set to pave the way for a multi-faceted strategic research and development (R&D) roadmap, focusing on the identification, optimization, investigation, and validation of broad-spectrum antivirals.
Full press release available here